Zynex (ZYXI) to Release Earnings on Wednesday

Zynex (NASDAQ:ZYXI) is anticipated to release its earnings data before the market opens on Wednesday, February 26th. Analysts expect Zynex to post earnings of $0.09 per share and revenue of $53.65 million for the quarter.

Zynex Stock Performance

ZYXI opened at $7.36 on Tuesday. The stock has a market cap of $234.42 million, a PE ratio of 49.07 and a beta of 0.54. The company has a current ratio of 3.94, a quick ratio of 3.15 and a debt-to-equity ratio of 1.66. Zynex has a 1 year low of $7.12 and a 1 year high of $13.77. The stock’s 50 day simple moving average is $7.91 and its 200-day simple moving average is $8.04.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $17.00 price objective on shares of Zynex in a research report on Friday, December 6th.

Insider Activity

In other Zynex news, CFO Daniel J. Moorhead sold 10,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $7.88, for a total value of $78,800.00. Following the sale, the chief financial officer now directly owns 26,299 shares in the company, valued at $207,236.12. This represents a 27.55 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Over the last ninety days, insiders have sold 30,000 shares of company stock worth $236,400. Company insiders own 52.13% of the company’s stock.

Zynex Company Profile

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.